Authors: Burtness, B Belker, M Stoltz, M Peccerillo, KM Lamb, LA Chmael, SE McKeon, A Clark, MB Winship, J Marsh, JC Pizzorno, G DeVita, VT

Citation: B. Burtness et al., A phase I study of the antimetabolite (E)-2 '-fluoromethylene-2 '-deoxycytidine (MDL 101,731) administered as a twice-weekly infusion, CANCER J, 6(5), 2000, pp. 309-315

Authors: Murren, JR DiStasio, SA Lorico, A McKeon, A Zuhowski, EG Egorin, MJ Sartorelli, AC Rappa, G

Citation: Jr. Murren et al., Phase I and pharmacokinetic study of novobiocin in combination with VP-16 in patients with refractory malignancies, CANCER J, 6(4), 2000, pp. 256-265

Authors: Murren, JR Peccerillo, K DiStasio, SA Li, X Leffert, JJ Pizzorno, G Burtness, BA McKeon, A Cheng, YC

Citation: Jr. Murren et al., Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer, CANC CHEMOT, 46(1), 2000, pp. 43-50